PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Manulife Financial Corp (MFC-PM.TO)
23.680.18 (-0.75%)
23.68 - 23.68
20.75 - 25.07
1.4K / 5.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
19.04%
Revenue growth exceeding 1.5x Insurance - Life median of 2.72%. Joel Greenblatt would verify if operating margins keep pace with this top-line surge.
19.04%
Gross profit growth exceeding 1.5x Insurance - Life median of 9.65%. Joel Greenblatt would check if cost advantages or brand equity drive this surge.
5.84%
EBIT growth 50-75% of Insurance - Life median of 7.79%. Guy Spier would be cautious about subpar efficiency or limited pricing power.
5.84%
Operating income growth 50-75% of Insurance - Life median of 7.79%. Guy Spier would question management’s efficiency measures.
11.41%
Net income growth near Insurance - Life median of 11.11%. Charlie Munger would see common industry factors at play.
11.39%
EPS growth 75-90% of Insurance - Life median of 12.90%. John Neff would want to see margin or revenue improvements to close the gap.
11.41%
Diluted EPS growth near Insurance - Life median of 12.10%. Charlie Munger would expect typical industry-level share usage and profit trends.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
21.67%
OCF growth of 21.67% while Insurance - Life is zero. Walter Schloss might see a modest positive difference, which can compound over time.
21.67%
FCF growth of 21.67% while Insurance - Life median is zero. Walter Schloss might see a slight edge that could compound over time.
155.30%
10Y revenue/share CAGR 1.25-1.5x Insurance - Life median of 107.37%. Mohnish Pabrai would see if consistent reinvestment or product expansions drive this gap.
118.35%
5Y revenue/share growth exceeding 1.5x Insurance - Life median of 50.16%. Joel Greenblatt would see if the company’s moat drives rapid mid-term expansion.
130.41%
3Y revenue/share growth exceeding 1.5x Insurance - Life median of 31.02%. Joel Greenblatt might see a short-term competitive advantage at play.
137.98%
OCF/share CAGR 1.25-1.5x Insurance - Life median of 94.83%. Mohnish Pabrai would see if disciplined capex and stable margins contribute to this advantage.
427.05%
OCF/share CAGR of 427.05% while Insurance - Life median is zero. Walter Schloss might see a slight advantage that can compound if momentum builds.
2171.56%
3Y OCF/share growth > 1.5x Insurance - Life median of 19.74%. Joel Greenblatt might see a recent competitive advantage translating into cash improvements.
342.70%
Net income/share CAGR exceeding 1.5x Insurance - Life median of 165.93% over a decade. Joel Greenblatt might see a standout compounder of earnings.
224.01%
5Y net income/share CAGR > 1.5x Insurance - Life median of 117.67%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
159.72%
3Y net income/share CAGR > 1.5x Insurance - Life median of 80.28%. Joel Greenblatt might see a recent surge from market share gains or cost synergy.
255.76%
Equity/share CAGR exceeding 1.5x Insurance - Life median of 14.63% over 10 years. Joel Greenblatt would see if a high ROE underlies this compounding advantage.
209.37%
5Y equity/share CAGR > 1.5x Insurance - Life median of 62.82%. Joel Greenblatt sees a possible ROE advantage or fewer share issuances boosting book value.
177.12%
3Y equity/share CAGR > 1.5x Insurance - Life median of 22.67%. Joel Greenblatt sees strong short-term returns on equity fueling net worth growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
5.27%
Asset growth exceeding 1.5x Insurance - Life median of 2.23%. Joel Greenblatt confirms strong expansions matched by adequate returns on those assets.
7.10%
BV/share growth exceeding 1.5x Insurance - Life median. Joel Greenblatt checks if consistent ROE or undervalued buybacks fuel this advantage.
13.32%
Debt growth far outpacing Insurance - Life median. Jim Chanos suspects over-leveraging or deteriorating financial discipline.
No Data
No Data available this quarter, please select a different quarter.
-0.98%
SG&A decline while Insurance - Life grows. Seth Klarman sees potential cost advantage or a risk if it hurts future growth.